Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Return on Sales (2017 - 2025)

Historic Return on Sales for Organogenesis Holdings (ORGO) over the last 9 years, with Q3 2025 value amounting to 0.14%.

  • Organogenesis Holdings' Return on Sales rose 400.0% to 0.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02%, marking a year-over-year change of 0.0%. This contributed to the annual value of 0.02% for FY2024, which is 300.0% down from last year.
  • According to the latest figures from Q3 2025, Organogenesis Holdings' Return on Sales is 0.14%, which was up 400.0% from 0.09% recorded in Q2 2025.
  • Organogenesis Holdings' 5-year Return on Sales high stood at 0.4% for Q4 2021, and its period low was 0.22% during Q1 2025.
  • Its 5-year average for Return on Sales is 0.04%, with a median of 0.03% in 2023.
  • In the last 5 years, Organogenesis Holdings' Return on Sales skyrocketed by 3600bps in 2021 and then tumbled by -3300bps in 2022.
  • Quarter analysis of 5 years shows Organogenesis Holdings' Return on Sales stood at 0.4% in 2021, then plummeted by -84bps to 0.06% in 2022, then tumbled by -109bps to 0.01% in 2023, then tumbled by -322bps to 0.02% in 2024, then surged by 694bps to 0.14% in 2025.
  • Its Return on Sales stands at 0.14% for Q3 2025, versus 0.09% for Q2 2025 and 0.22% for Q1 2025.